A Study to Develop and Validate a Device for Continuous Blood Flow Lactate Monitoring


About this study

The purpose of this study is to use patient blood and blood data to help develop and then validate a device to continuously monitor blood levels of lactate in the critically ill.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria

  • Clinical blood samples obtained from patients in the Intensive Care Unit of Mayo Clinic Arizona
  • Only those patients who are having a lactate drawn for clinical management purposes will be included in the study
  • Informed consent for the study will be obtained from the patients or their surrogate

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status

Scottsdale/Phoenix, Ariz.

Mayo Clinic principal investigator

Ayan Sen, M.D.

Closed for enrollment

More information


Publications are currently not available

Additional contact information

Non-cancer trials contact form

Phone: 800-664-4542 (toll-free)

International patient clinical studies questions